Advertisement

Ads Placeholder
Loading...

Ligand Pharmaceuticals, Inc.

LGNDZ•PNK
Healthcare
Medical - Pharmaceuticals
$0.002
$0.00(19.93%)
U.S. Market opens in 50h 44m

Ligand Pharmaceuticals, Inc. (LGNDZ) Stock Overview

Explore Ligand Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap36.1K
P/E Ratio0.00
EPS (TTM)N/A
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.01
1 Year Target$0.00

LGNDZ Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ligand Pharmaceuticals, Inc. (LGNDZ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 36.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
19.93%
5-Day Change
24.55%
1-Month Change
0.61%
3-Month Change
-73.37%
6-Month Change
-65.83%
Year-to-Date (YTD) Change
-73.37%
1-Year Change
-43.41%
3-Year Change
-43.41%
5-Year Change
-43.41%
All-Time (Max) Change
-43.41%

Contact Information

https://www.ligand.com
NaN
555 Heritage Drive, Jupiter, NaN, NaN

Company Facts

680 Employees
CountryUS
Actively Trading

Frequently Asked Questions